It has been reported that increased expression of UCP-2 in the vasculature may prevent the development of atherosclerosis in patients with increased production of reactive oxygen species, as in the diabetes, obesity or hypertension. This evidence concerns the gene UCP2 and obesity due to melanocortin 4 receptor deficiency.